Abstract
This chapter discusses the role of informatics pharmacists in health care and how the profession can spearhead efforts to tackle future challenges in the medication use process. With the emergence of artificial intelligence (AI) and its potential impact on the healthcare setting, both the risks and its benefits are examined as it pertains to the pharmacy profession. As our healthcare ecosystem becomes more dependent on data, especially for AI, the priority for the pharmacy profession is clear: adoption and implementation of medication-related standards as well as closing the gaps in pharmacy informatics education. Lastly, the chapter provides examples of collaborations between informatics pharmacists and other healthcare professionals to emphasize the complexity and nuances of implementing health information technology.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Pitre M, Thickson N. Should pharmacy informatics officer positions be based in, and report to, the pharmacy department, rather than the health information technology department? Can J Hosp Pharm. 2011;64(6):459–61.
Fox BI, Flynn AJ, Fortier CR, Clauson KA. Knowledge, skills, and resources for pharmacy informatics education. Am J Pharm Educ. 2011;75(5):93.
ASHP. Statement on the pharmacist’s role in clinical informatics. Am J Health Syst Pharm. 2016;73(6):410–3.
Dustin Waters C. Pharmacist-driven antimicrobial stewardship program in an institution without infectious diseases physician support. Am J Health Syst Pharm. 2015;72(6):466–8.
Fox BI, Pedersen CA, Gumpper KF. ASHP national survey on informatics: assessment of the adoption and use of pharmacy informatics in US hospitals—2013. Am J Health Syst Pharm. 2015;72(8):636–55.
Woodhead V. Why pharmacists should consider clinical data management as a career [Internet]. The Pharmaceutical Journal. 2003. https://www.pharmaceutical-journal.com/news-and-analysis/features/why-pharmacists-should-consider-clinical-data-management-as-a-career/20008578.article?firstPass=false. Accessed 11 Apr 2020.
Vest TA, Gazda NP, Schenkat DH, Eckel SF. Practice-enhancing publications about the medication use process in 2017. Am J Health Syst Pharm. 2019;76(10):667–76.
Executive summary of the 2019 ASHP Commission on Goals: impact of artificial intelligence on healthcare and pharmacy practice. Am J Health Syst Pharm. 2019;76(24):2087–92.
Vermeulen LC, Swarthout MD, Alexander GC, Ginsburg DB, Pritchett KO, White SJ, et al. ASHP Foundation pharmacy forecast 2020: strategic planning advice for pharmacy departments in hospitals and health systems. Vermeulen LC, Zellmer WA, editors. Am J Health Syst Pharm. 2020;77(2):84–112.
Matheny M, Israni ST, Whicher D. Artificial intelligence in health care: the hope, the hype, the promise, the peril [Internet]. National Academy of Medicine. 2019; p. 269 (The Learning Health System). https://nam.edu/wp-content/uploads/2019/12/AI-in-Health-Care-PREPUB-FINAL.pdf. Accessed 5 Mar 2020.
Flynn A. Using artificial intelligence in health-system pharmacy practice: finding new patterns that matter. Am J Health Syst Pharm. 2019;76(9):622–7.
Segal G, Segev A, Brom A, Lifshitz Y, Wasserstrum Y, Zimlichman E. Reducing drug prescription errors and adverse drug events by application of a probabilistic, machine-learning based clinical decision support system in an inpatient setting. J Am Med Inform Assoc. 2019;26(12):1560–5.
Wong A, Plasek JM, Montecalvo SP, Zhou L. Natural language processing and its implications for the future of medication safety: a narrative review of recent advances and challenges. Pharmacotherapy. 2018;38(8):822–41.
Danysz K, Cicirello S, Mingle E, Assuncao B, Tetarenko N, Mockute R, et al. Artificial intelligence and the future of the drug safety professional. Drug Saf. 2019;42(4):491–7.
Maharao N, Antontsev V, Wright M, Varshney J. Entering the era of computationally driven drug development. Drug Metab Rev. 2020;21:1–16.
Galozy A, Nowaczyk S, Sant’Anna A, Ohlsson M, Lingman M. Pitfalls of medication adherence approximation through EHR and pharmacy records: definitions, data and computation. Int J Med Inf. 2020;136:104092.
Matheny ME, Whicher D, Israni ST. Artificial intelligence in health care: a report from the National Academy of Medicine. JAMA. 2020;323(6):509–10.
Maddox TM, Rumsfeld JS, Payne PRO. Questions for artificial intelligence in health care. JAMA. 2019;321(1):31–2.
Bodenreider O, Cornet R, Vreeman DJ. Recent developments in clinical terminologies—SNOMED CT, LOINC, and RxNorm. Yearb Med Inform. 2018;27(1):129–39.
Integrated Health Information Systems (IHiS). Integrated Health Information Systems (IHiS) Standards [Internet]. 2018. https://cms.ihis.com.sg/Standards/Pages/Default.aspx. Accessed 29 Apr 2020.
RxNorm overview [Internet]. U.S. National Library of Medicine. https://www.nlm.nih.gov/research/umls/rxnorm/overview.html. Accessed 30 Apr 2020.
Khairat S, Sandefer R, Marc D, Pyles L. A review of biomedical and health informatics education: a workforce training framework. J Hosp Adm. 2016;5(5):10.
Weiner JP, Kfuri T, Chan K, Fowles JB. “e-Iatrogenesis”: the most critical unintended consequence of CPOE and other HIT. J Am Med Inform Assoc. 2007;14(3):387–8.
Dumitru D. The pharmacy informatics primer. 1st ed. Bethesda, MD: American Society of Health-System Pharmacists (ASHP); 2008. p. 264.
Quist AJL, Hickman T-TT, Amato MG, Volk LA, Salazar A, Robertson A, et al. Analysis of variations in the display of drug names in computerized prescriber-order-entry systems. Am J Health Syst Pharm. 2017;74(7):499–509.
ISMP guidelines for safe electronic communication of medication information [Internet]. Institute for Safe Medication. Practices (ISMP). 2019. https://www.ismp.org/node/1322. Accessed 17 Apr 2020.
Cramb A. Giving up smoking? Take a Viagra. The Telegraph [Internet]. 2006. https://www.telegraph.co.uk/news/uknews/1536890/Giving-up-smoking-Take-a-Viagra.html. Accessed 17 Apr 2020.
ASHP Section of Pharmacy Informatics and Technology. ASHP guidelines on pharmacy planning for implementation of computerized provider-order-entry systems in hospitals and health systems. Am J Health Syst Pharm. 2011;68:e9–31.
Biltoft J, Finneman L. Clinical and financial effects of smart pump–electronic medical record interoperability at a hospital in a regional health system. Bull Am Soc Hosp Pharm. 2018;75(14):1064–8.
Dentzer S. Creating the future of artificial intelligence in health-system pharmacy. Am J Health Syst Pharm. 2019;76(24):1995–6.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Appendix: Answers to Review Questions
Appendix: Answers to Review Questions
-
1.
Which of the following scenarios has AI been studied as an application within the practice of pharmacy?
-
(a)
Detection of adverse drug events
-
(b)
Drug discovery
-
(c)
Drug selection
-
(d)
Inventory management
-
(e)
All of the above
Explanation: All of the following have been studied as an application of AI in pharmacy.
-
2.
Which of the following are important considerations in the development and deployment of AI?
-
(a)
Training AI models with limited data sets to avoid complexity.
-
(b)
Trusting the prediction outcomes, as algorithms have proven to outperform humans.
-
(c)
Data provenance and validation of data used to train AI models.
-
(d)
Mismatch of demand and supply in AI deployment due to a surplus of trained individuals.
Explanation: (a) is incorrect as training models require large data sets that can be upwards of tens of thousands of records; (b) is incorrect as data quality issues can lead to incorrect assumptions and should be appropriately scrutinized; (d) is incorrect as there is a shortage of trained individuals to effectively deploy AI.
-
3.
Which of the following clinical standards is NOT a medication standard?
-
(a)
AMT
-
(b)
LOINC
-
(c)
RxNorm
-
(d)
dm+d
-
(e)
SDD
Explanation: LOINC is a terminology standard for health measurements, observations, and documents. It is not a medication standard.
-
4.
True or False: Existing standards coupled with EHRs are sufficient for the widespread deployment of AI.
-
(a)
True
-
(b)
False
Explanation: Further maturation of existing infrastructure, especially as it pertains to enriching data quality and representation, is needed before we can achieve widespread deployment of AI. Moreover, near-term solutions should be focused on augmented intelligence rather than full automation. See the article from the National Academy of Medicine for further reading.
-
5.
Which of the following will unlikely lead to e-iatrogenesis?
-
(a)
Designing poor user interfaces for CPOE.
-
(b)
Configuring medication records with different display names to ensure variability within the EHR.
-
(c)
Coordinating with stakeholders to harmonize data sets between smart pumps and EHR medication formularies.
-
(d)
Designing workflows and tools to be fully automated to avoid human-computer interaction altogether.
Explanation: all of the choices except (c) were listed as examples that could lead to e-iatrogenesis. Only (c) was an example of how to avoid e-iatrogenesis.
Rights and permissions
Copyright information
© 2022 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Franky, Fung, B.K. (2022). The Pharmacist’s View: Patient-Centered Care Through the Lens of a Pharmacist. In: Hübner, U.H., Mustata Wilson, G., Morawski, T.S., Ball, M.J. (eds) Nursing Informatics . Health Informatics. Springer, Cham. https://doi.org/10.1007/978-3-030-91237-6_6
Download citation
DOI: https://doi.org/10.1007/978-3-030-91237-6_6
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-91236-9
Online ISBN: 978-3-030-91237-6
eBook Packages: MedicineMedicine (R0)